Psychiatrist

Mark Fabi, M.D.

834 Chestnut St, Suite 427, Philadelphia, Pennsylvania, 19107-5127

About Mark Fabi

Mark Fabi is a psychiatrist based in Philadelphia, Pennsylvania who is specialized in Psychiatry. Active license number of Mark Fabi is MD036925E for Psychiatry in Pennsylvania. His current practice location is 834 Chestnut St, Suite 427, Philadelphia. Patients can contact him at 215-625-3601 or can fax him at 215-629-1306. Mark Fabi, M.D., specializes in Psychiatry and his NPI number (Unique professional ID assigned by NPPES) is 1356479604.

Mark Fabi specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Practice Information

Mark Fabi's specialty, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.

Provider Name Mark Fabi
Specialization Psychiatry
Credentials M.D.
Gender Male
Practice Address: 834 Chestnut St, Suite 427
Philadelphia, PA - 19107-5127
Fax 215-629-1306

Professional Identification Codes

NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to healthcare providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.

NPI Number1356479604
NPI Enumeration Date: 01 Mar, 2007
NPI Last Update On: 08 Jul, 2007

Medical Licenses:

Healthcare professionals can hold one or more medical licenses for different specialties in the same state or different states. Related medical licenses for Mark Fabi are as mentioned below.

License NumberSpecializationStateStatus
MD036925EPsychiatry PennsylvaniaPrimary

Mailing Address

Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned Practice address.

Mark Fabi
834 Chestnut St, Suite 427
Philadelphia, PA - 19107-5127
Phone: 215-625-3601
Fax: 215-629-1306

Book an Appointment with Mark Fabi

To schedule an appointment, contact Mark Fabi at 834 Chestnut St, Suite 427, Philadelphia, Pennsylvania or call the phone number listed below.

Book an Appointment

Frequently Asked Questions

Below are some commonly asked questions about Mark Fabi:

Mark Fabi is a psychiatrist specializing in Psychiatry. He specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Yes, Mark Fabi is currently accepting new patients. To schedule an appointment, contact the office directly and schedule an appointment.
*Availability may change. Please contact the office directly to ask about appointments.

Mark Fabi practices at 834 Chestnut St, Suite 427, Philadelphia, Pennsylvania, 19107-5127.

To schedule an appointment with Mark Fabi, please contact the office at 215-625-3601.

Reviews & Feedback

Have you visited Mark Fabi? Share your experience to help others looking for a psychiatrist in Philadelphia, PA.

Read Reviews / Give Feedback
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 November, 2026.